Saturday 17 October 2026
Export LUCY’s income statement to Excel — free account
Innovative Eyewear, Inc.
LUCY Healthcare Medical Instruments & Supplies
Innovative Eyewear, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.7 million, up 62.7% from fiscal 2024. In the quarter to June 2026, revenue grew 74.5%, EPS grew 60.6%, free cash flow grew 9.61% and total debt fell 92.4%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.
0.79
0.05
−5.95%
Follow LUCY
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
4 | 3 | 4 | 3 |
+8 more TTM periods Free account |
| (84.58%) | (102.40%) | (83.60%) | (74.10%) | ||
| (79.21%) | (93.24%) | (75.99%) | (68.92%) | ||
ROIC |
(168.07%) | (206.51%) | (205.50%) | (222.70%) | |
Return on Tangible Assets |
(122.90%) | (105.38%) | (89.82%) | (80.30%) | |
Average Days of Receivables |
14.59 | 8.76 | 19.50 | 12.72 | |
Free Cash Flow per Share |
(1.14) | (1.21) | (1.88) | (1.69) | |
Free Cash Flow |
(7.31) | (7.53) | (7.52) | (8.21) | |
Capital Expenditures |
(0.11) | (0.08) | (0.25) | (0.34) | |
| Other line items | |||||
Cash ROIC |
(68.65%) | (53.54%) | (48.22%) | (44.89%) | |
Accounts Receivable Turnover |
35.10 | 36.98 | 21.28 | 29.12 | |
Accounts Payable Turnover |
5.37 | 3.62 | 2.50 | 2.68 | |
Inventory Turnover |
1.26 | 1.36 | 1.22 | 1.15 | |
Average Days of Payables |
68.93 | 154.94 | 171.74 | 152.67 | |
Days of Inventory on Hand |
308.83 | 311.82 | 380.56 | 426.27 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
15.44% | 21.90% | 27.25% | 34.43% | |
Selling, General and Administrative Expense of Revenue |
252.27% | 291.62% | 307.97% | 323.97% | |
Share Based Compensation of Revenue |
23.31% | 25.55% | 27.74% | 33.28% | |
Operating CF/Net income |
0.94 | 0.92 | 0.96 | 1.00 | |
Depreciation/Fixed assets |
3.82 | 2.60 | 2.19 | 2.45 | |
Capex/Depreciation |
(0.89) | (0.58) | (1.85) | (2.39) | |
Revenue per Share |
0.53 | 0.48 | 0.67 | 0.49 | |
Operating CF per Share |
(1.12) | (1.19) | (1.82) | (1.62) | |
Capex per Share |
(0.02) | (0.01) | (0.06) | (0.07) | |
Capex to Sales |
0.03 | 0.03 | 0.09 | 0.14 |
Columns are period end dates